A 44 Channel suprachoroidal retinal prosthesis : two year safety and stability results

被引:0
|
作者
Allen, Penelope J. [1 ,2 ]
Nayagam, David A. X. [3 ,4 ]
Epp, Stephanie [3 ]
Luu, Chi D. [1 ,2 ]
Barnes, Nick [5 ]
Kolic, Maria [1 ]
Baglin, Elizabeth K. [1 ]
Abbott, Carla J. [1 ,2 ]
Briggs, Robert [6 ]
Yeoh, Jonathan [1 ]
Kentler, William G. [7 ]
Kvansakul, Jessica [3 ]
Titchener, Samuel A. [3 ]
Petoe, Matthew A. [3 ]
Williams, Christopher E. [3 ]
机构
[1] Ctr Eye Res Australia Ltd, East Melbourne, Vic, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Surg Ophthalmol, Melbourne, Vic, Australia
[3] Bion Inst, East Melbourne, Vic, Australia
[4] Univ Melbourne, Pathol, Melbourne, Vic, Australia
[5] Australian Natl Univ, Res Sch Elect Energy & Mat Engn, Canberra, ACT, Australia
[6] Univ Melbourne, Surg Otolaryngol, Melbourne, Vic, Australia
[7] Univ Melbourne, Sch Engn, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3164
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation
    Saito, Masaaki
    Iida, Tomohiro
    Kano, Mariko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (02) : 211 - 220
  • [42] Primary total hip arthroplasty using a modular proximally coated prosthesis in patients older than 70 - Two to eight year results
    Sporer, SM
    Obar, RJ
    Bernini, PM
    JOURNAL OF ARTHROPLASTY, 2004, 19 (02): : 197 - 203
  • [43] A two-year study to assess the efficacy, safety, and tolerability of taranabant in obese patients: 52 week results
    Moreno, M.
    Gantz, I.
    Erondu, N.
    Suryawanshi, S.
    Musser, B.
    Nayee, J.
    Johnson-Levonas, A. O.
    Heymsfield, S.
    Amatruda, J.
    CIRCULATION, 2008, 118 (12) : E415 - E415
  • [44] Two-year safety of apremilast in patients with moderate to severe plaque psoriasis: Results from ESTEEM 1
    Papp, K.
    Reich, K.
    Sobell, J. M.
    Menter, A.
    Lacour, J. P.
    Chimenti, S.
    Hu, C. C.
    Day, R. M.
    Shah, K.
    Griffiths, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 67 - 67
  • [45] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S160 - S160
  • [46] A two-year study to assess the efficacy, safety, and tolerability of taranabant in obese patients: 52 week results
    Proietto, J.
    Gantz, I
    Carr, R. D.
    Erondu, N.
    Moreno, M.
    Suryawanshi, S.
    Musser, B.
    Nayee, J.
    Johnson-Levonas, A. O.
    Heymsfield, S.
    Amatruda, J.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S22 - S22
  • [47] A two-year study to assess the efficacy, safety, and tolerability of taranabant in obese patients: 52 week results
    Gantz, Ira
    Erondu, Ngozi
    Suryawanshi, Shailaja
    Musser, Bret
    Nayee, Jagriti
    Johnson-Levonas, Amy O.
    Heymsfield, Steven
    Amatruda, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A326 - A327
  • [48] A TWO-YEAR STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF TARANABANT IN OBESE PATIENTS: 52 WEEK RESULTS
    Carr, R. D.
    Gantz, I.
    Erondu, N.
    Moreno, M.
    Suryawanshi, S.
    Musser, B.
    Nayee, J.
    Johnson-Levonas, A. O.
    Heymsfield, S.
    Amatruda, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 12 - 12
  • [49] Linear stability analysis of RELAP5 two-fluid model in nuclear reactor safety results
    Saraswat, S. P.
    Munshi, P.
    Allison, C.
    ANNALS OF NUCLEAR ENERGY, 2020, 149 (149)
  • [50] Stability of Woodchips Biochar and Impact on Soil Carbon Stocks: Results from a Two-Year Field Experiment
    Criscuoli, Irene
    Ventura, Maurizio
    Wiedner, Katja
    Glaser, Bruno
    Panzacchi, Pietro
    Ceccon, Christian
    Loesch, Maximilian
    Raifer, Barbara
    Tonon, Giustino
    FORESTS, 2021, 12 (10):